PuSH - Publication Server of Helmholtz Zentrum München

42 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Wang, J. et al.: Spatial metabolomics identifies distinct tumor-specific subtypes in gastric cancer patients. Clin. Cancer Res., DOI: 10.1158/1078-0432.CCR-21-4383 (2022)
2.
Weber, P. et al.: Therapy-related transcriptional subtypes in matched primary and recurrent head and neck cancer. Clin. Cancer Res. 28, 1038-1052 (2022)
3.
Anande, G.* et al.: RNA splicing alterations induce a cellular stress response associated with poor prognosis inAcute Myeloid Leukemia. Clin. Cancer Res. 26, 3597-3607 (2020)
4.
Hulstaert, E.* et al.: Charting extracellular transcriptomes in The Human Biofluid RNA Atlas. Clin. Cancer Res. 26, 33-34 (2020)
5.
Multhoff, G.* et al.: Targeted natural killer cell-based adoptive immunotherapy for the treatment of patients with NSCLC after radiochemotherapy: A randomized phase II clinical trial. Clin. Cancer Res. 26, 5368-5379 (2020)
6.
Hess-Rieger, J. et al.: A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV-infection. Clin. Cancer Res. 25, 1505-1516 (2019)
7.
Karches, C.H.* et al.: Bispecific antibodies enable synthetic agonistic receptor-transduced T cells for tumor immunotherapy. Clin. Cancer Res. 25, 5890-5900 (2019)
8.
Hensel, T.* et al.: Combined targeting of the Ewing sarcoma transcriptional program by blocking epigenetic readers and transcription initiation via EWS-FLI1. Clin. Cancer Res. 24, 56-56 (2018)
9.
Schmidt, S.* et al.: Development and validation of a gene signature for patients with head and neck squamous cell carcinomas treated by postoperative radio(chemo)therapy. Clin. Cancer Res. 24, 1364-1374 (2018)
10.
von Heyking, K.* et al.: The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype promoting lung metastasis in Ewing sarcoma. Clin. Cancer Res. 24, 57-57 (2018)
11.
Diot, G.* et al.: Multi-spectral optoacoustic tomography (MSOT) of human breast cancer. Clin. Cancer Res. 23, 6912-6922 (2017)
12.
Lamberts, L.E.* et al.: Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: A phase I feasibility study. Clin. Cancer Res. 23, 2730-2741 (2016)
13.
Friemel, J.* et al.: Intratumor heterogeneity in hepatocellular carcinoma. Clin. Cancer Res. 21, 1951-1961 (2015)
14.
Groß, C.* et al.: Model matters: Differences in orthotopic rat hepatocellular carcinoma physiology determine therapy response to sorafenib. Clin. Cancer Res. 21, 4440-4450 (2015)
15.
Lee, M.S. et al.: Targeting PI3K/mTOR signaling displays potent antitumor efficacy against nonfunctioning pituitary adenomas. Clin. Cancer Res. 21, 3204-3215 (2015)
16.
Weber, A.* ; O'Connor, T.* & Heikenwälder, M.: Next generation of preclinical liver cancer models. Clin. Cancer Res. 21, 4254-4256 (2015)
17.
Wulfkuhle, J.D.* et al.: Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin. Cancer Res. 18, 6426-6435 (2012)
18.
Butterfield, L.H.* et al.: Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin. Cancer Res. 17, 3064-3076 (2011)
19.
Ehrhardt, H. ; Wachter, F. ; Maurer, M. ; Stahnke, K.* & Jeremias, I.: Important role of Caspase-8 for chemo-sensitivity of ALL cells. Clin. Cancer Res. 17, 7605-7613 (2011)
20.
Leisegang, M.* et al.: T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy. Clin. Cancer Res. 16, 2333-2343 (2010)